Patient
For understanding support.
Informed by more than six decades of experience in radiopharmaceuticals, support from Lantheus Link can help you access, schedule and get to your prescribed PYLARIFY® (piflufolastat F 18) injection scan.
Actor portrayal
Coverage & Insurance
One-on-one guidance for understanding your plan and working through any possible coverage hurdles.
Affordability
Personalized assistance with financial aid options that may help cover out-of-pocket costs for your scan.
Education & Resources
Education, tools and connection to advocacy groups that understand what you’re going through.
Logistics Support
Ongoing support with choosing an imaging site, scheduling appointments and finding transportation.
A single source of support.
From enrollment on, a dedicated Care Coordinator will help with the ins and outs of getting your scan. In addition to guiding you through insurance, affordability and logistics, they’ll onboard you to our program and set expectations for what your scan entails. If you need help, you can turn to them.
Coverage & Insurance
First things first: We’ll work with your physician’s office to verify your insurance coverage. Then, we’ll inform you of what your plan covers, as well as any out-of-pocket costs that may be associated with your scan.
Once enrolled, your dedicated Care Coordinator can help you understand your insurance plan, including deductibles and copayments, and uncover possible coverage restrictions.
Clarity is critical when it comes to the cost of your scan. We’ll be sure to communicate the details of any out-of-pocket expenses not covered by your insurance so you can plan for what’s ahead.
Affordability
If you incur any out-of-pocket costs associated with your scan, you may be eligible for additional financial assistance. Once enrolled, contact your Care Coordinator to learn more.
You can reach them at 844-339-8514 or support@lantheuslink.com.
Education & Resources
Learning materials
Find clarity and comfort in knowing what’s ahead with educational materials designed to help you prepare for your scan and enrollment in Lantheus Link.
External resources
We can connect you to a variety of resources for information and understanding ahead of your scan. Ask your Care Coordinator about advocacy organizations that may be able to help.
What to expect
Support is many things. So Lantheus Link is, too.
We’re here to help connect the dots leading up to your scan, from coverage support to appointment reminders. Once enrolled, here’s what you can expect.
Verifying Coverage
We’ll work with your physician to verify your insurance coverage and handle any denials and appeals.
Scan Facility Identification
We can provide in-network imaging center options for you and your physician to choose from.
Scheduling & Onboarding
We’ll call you to discuss benefits, guide you through appointment scheduling and plan transportation logistics.
Reminders & Follow-ups
Leading up to your scan, we’ll send reminders and assist with rescheduling as needed.
Verifying Coverage
We’ll work with your physician to verify your insurance coverage and handle any denials and appeals.
Scan Facility Identification
We can provide in-network imaging center options for you and your physician to choose from.
Scheduling & Onboarding
We’ll call you to discuss benefits, guide you through appointment scheduling and plan transportation logistics.
Reminders & Follow-ups
Leading up to your scan, we’ll send reminders and assist with rescheduling as needed.
About Your Scan
You no doubt have questions about your scan and how to prepare. This is a great place to start. Review the following details or visit the PYLARIFY® website to get a better idea of what to expect before, during and after your scan.
BEFORE
It is important to stay hydrated before your scan. While fasting is not required, your doctor may ask you to.
Upon arrival:
- Your weight and height will be recorded
- An intravenous (IV) catheter line will be placed in a vein in your arm or another suitable location
- You’ll receive an injection of PYLARIFY® one hour prior to your scan, during which time it will circulate through your bloodstream
- You may be asked to use the restroom after your injection and prior to your scan
DURING
About one hour after your injection, your scan will begin. The scan could last up to 40 minutes.
During this time:
- A PET/CT technologist or nurse will assist you
- You’ll lie on your back on the scanner bed with your arms raised above your head
- The scanner bed will move slowly into the scanner and go all the way up to your head
- You may be asked to change body positions
AFTER
When your scan is complete, the results will be sent to your doctor.
In the meantime:
- Continue to hydrate and go to the bathroom for the first few hours to reduce radiation exposure
- Schedule a follow-up appointment with your doctor to discuss your results
Logistics Support
Our team offers personalized assistance with appointment scheduling, confirmation and transportation so you always have help with what’s next.
Imaging site assistance
Use our scan facility locator or work with one of our Care Coordinators to find a convenient, in-network imaging site.
Appointment planning
On our onboarding call, we’ll walk you through how to schedule an appointment at the chosen facility. Our team can then set up reminders to be sent two days before the scan date or help with rescheduling.
Transportation arrangements
We can also help you verify any travel benefits through your insurance or find potential transportation options to and from your imaging site. Talk to your Care Coordinator to learn more.
Frequently Asked Questions
About the Program
Lantheus Link is a patient support program offering services to help with accessing, scheduling and getting to a diagnostic scan with approved usage of the PYLARIFY® imaging agent.
Any person prescribed a procedure consistent with approved usage of our diagnostic imaging agent is eligible to enroll. Caregivers to people with a diagnosis consistent with approved use are also welcome to enroll.
Work with your physician to fill out the enrollment form. Your physician will submit the completed form on your behalf.
Once your enrollment in Lantheus Link is confirmed, you will receive a call from your Care Coordinator to walk you through the program and provide the necessary next steps.
When working with your physician to fill out the enrollment form, you may indicate your preferred communication methods in the appropriate form fields. You can update your communication preferences at any time.
Once enrolled, your assigned Care Coordinator will be your ongoing designated point of contact, there to offer assistance leading up to and after your scan.
If you have any questions, you can contact our team Monday through Friday, 8:00 am to 8:00 pm ET, at 844-339-8514 or support@lantheuslink.com.
Coverage & Insurance
Yes, those without insurance are still eligible to enroll in Lantheus Link.
Your Care Coordinator will conduct a benefits investigation to verify your insurance benefits, deductibles and copayments as well as any coverage restrictions and anticipated out-of-pocket costs. They will go over these findings during your onboarding call.
Affordability
Lantheus Link can help you understand your insurance coverage and anticipated out-of-pocket expenses, as well as provide information on financial assistance organizations that may be able to help make your procedure more affordable.
There are numerous financial aid organizations that may be able to help you with the cost of your scan based on your eligibility. Once enrolled, ask your Care Coordinator for information on organizations that may be able to assist you.
Education & Resources
A PET scan is an imaging test that helps doctors look for disease sites in the body. A PET scan uses an imaging agent—like PYLARIFY®—that contains a small amount of radioactive tracer to make disease sites visible. PYLARIFY® is an advanced diagnostic imaging agent that helps create clearer images for doctors. For more information, visit the PYLARIFY® website.
No, PYLARIFY® is currently only available in the United States.
Logistics Support
If your scan facility doesn’t use PYLARIFY®, your Care Coordinator can assist you in communicating with your doctor to confirm the best next steps.
As part of our benefits investigation, we will determine whether you have transportation coverage through insurance. We can also provide information on external transportation assistance options. Talk to your Care Coordinator to learn more.
You can use our scan facility locator to find an imaging site in your area and work with your Care Coordinator directly to determine if it is in your network.
Once your scan has been scheduled, your Care Coordinator will offer you the option to sign up for scan reminders.
You should call your imaging site or Care Coordinator to go through the necessary steps for rescheduling.
Sign up for support.
Work with your physician to complete the enrollment form to get started with support from Lantheus Link.
Questions? We’re here to help Monday through Friday, 8:00 am to 8:00 pm ET, at 844-339-8514
or support@lantheuslink.com.
INDICATION
PYLARIFY (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer:
- with suspected metastasis who are candidates for initial definitive therapy.
- with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.
IMPORTANT SAFETY INFORMATION
Contraindications
None.
Warnings and Precautions
Risk of Image Misinterpretation
Imaging interpretation errors can occur with PYLARIFY imaging. A negative image does not rule out the presence of prostate cancer and a positive image does not confirm the presence of prostate cancer. The performance of PYLARIFY for imaging of patients with biochemical evidence of recurrence of prostate cancer seems to be affected by serum PSA levels. The performance of PYLARIFY for imaging of metastatic pelvic lymph nodes prior to initial definitive therapy seems to be affected by risk factors such as Gleason score and tumor stage. PYLARIFY uptake is not specific for prostate cancer and may occur with other types of cancer as well as non-malignant processes and in normal tissues. Clinical correlation, which may include histopathological evaluation of the suspected prostate cancer site, is recommended.
Hypersensitivity Reactions
Monitor patients for hypersensitivity reactions, particularly patients with a history of allergy to other drugs and foods. Reactions may be delayed. Always have trained staff and resuscitation equipment available.
Radiation Risks
Diagnostic radiopharmaceuticals, including PYLARIFY, expose patients to radiation. Radiation exposure is associated with a dose-dependent increased risk of cancer. Ensure safe handling and preparation procedures to protect patients and health care workers from unintentional radiation exposure. Advise patients to hydrate before and after administration and to void frequently after administration.
Adverse Reactions
The most frequently reported adverse reactions were headaches, dysgeusia and fatigue, occurring at rate of ≤2% during clinical studies with PYLARIFY. In addition, a delayed hypersensitivity reaction was reported in one patient (0.2%) with a history of allergic reactions.
Drug Interactions
Androgen deprivation therapy (ADT) and other therapies targeting the androgen pathway, such as androgen receptor antagonists, may result in changes in uptake of PYLARIFY in prostate cancer. The effect of these therapies on performance of PYLARIFY PET has not been established.
To report suspected adverse reactions for PYLARIFY, call 1-800-362-2668 or contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
For important risk and use information about PYLARIFY Injection, please see Full Prescribing information.